CSV and CSA FAQs: Practical Answers for Life Sciences Validation Teams
Get practical answers about CSV, CSA, risk-based testing, assurance needs, documentation, requirements, and ValGenesis support for software validation.
.webp)
Latest News
Does Annex 22 Close the Door on GenAI in Validation?
Oct 1, 2026, 9:00:04 AM | Explore the implications of draft EU GMP Annex 22 on generative AI in validation, focusing on risk management and responsible governance in GxP environments.
All Blog Posts
Does Annex 22 Close the Door on GenAI in Validation?
Explore the implications of draft EU GMP Annex 22 on generative AI in validation, focusing on risk management and responsible governance in GxP environments.
CSV and CSA FAQs: Practical Answers for Life Sciences Validation Teams
Get practical answers about CSV, CSA, risk-based testing, assurance needs, documentation, requirements, and ValGenesis support for software validation.
Your Validation Documents Are Digital, But Can the Data Travel — and Enable AI?
Explore how the shift from paper to digital validation in life sciences impacts data usability and AI potential. Discover the importance of connected data.
Catching Validation Anomalies with Automated Verification
Discover how automated verification enhances validation processes by catching anomalies early, improving accuracy, and enabling better decision-making.
What Life Science Organizations Should Demand from Trustworthy, Governed AI
Discover what life science organizations should expect from AI for true digital transformation, focusing on governed execution and lifecycle integration.
Commissioning, Qualification, and Validation: CQV FAQs for Life Sciences Teams
Get answers to the most common commissioning, qualification, and validation questions, from CQV fundamentals and compliance to AI and digital validation.
From AI Assistance to Controlled and Governed Execution: How AI in Validation Reaches Maturity
Explore how AI evolves from enhancing productivity to enabling governed execution in validation, transforming organizational efficiency and compliance.
IQ/OQ/PQ Refresher: How Qualification Evidence Evolves Across the Lifecycle
Streamline your qualification process by understanding how IQ, OQ, and PQ evidence builds across the lifecycle, enhancing efficiency and traceability.
Kneat's Comparison of ValGenesis Raises Questions About Its Methodology
Kneat ranked itself above ValGenesis without publishing a buyer-grade methodology. In validation, such claims should be tested against verifiable evidence.
.webp)
Why Validation Review Needs an Exception-based Model
Scale validation review without scaling review burden. Learn how reusable validation assets and exception-based review support faster, risk-focused CQV.
What Regulators Expect in AI-Powered Validation: Moving from Data Integrity to Decision Integrity
AI-assisted validation depends on evidence that can be trusted. Regulators expect to see clear human ownership and documented review of AI outputs.
Regulatory Scrutiny: Why a Paperless Approach Is a Non-Negotiable in CQV
Discover why transitioning to a paperless approach in CQV is essential to meet regulatory expectations and ensure data integrity in pharma manufacturing.
Access Your Logbook Data Instantly with ValGenesis iOps
Transform your logbook data into a strategic asset with ValGenesis e-Logbook for enhanced compliance, decision-making, and operational efficiency.
How ValGenesis Validation Lifecycle Suite Supports the Application of AI-Powered CQV Workflows
See how ValGenesis Validation Lifecycle Suite uses AI to streamline commissioning, qualification, and validation while strengthening compliance.
Validation Is Stuck in the Past — and Holding Back Pharma Innovation
Explore how automated validation tools and AI-driven software are reshaping pharma’s approach to speed, quality, and compliance in CSV, CSA, CQV.
All Tags
Featured Content
Quality Risk Management
Finding the Root Cause in mAB Production: a ValGenesis Story
Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.
Written by
Sofia Santos
Tech Transfer & Process Scale-up
How to Accelerate Process Scale-Up With Effective Tech Transfer
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
Written by
Sofia Santos
Cleaning Validation
Risk-Based Cleaning Validation: A Lifecycle Approach
Explore the evolution of pharmaceutical cleaning validation from compliance-focused practices to a risk-based, lifecycle-driven approach.
Written by
Kenneth Pierce
CSV and the Shift to CSA
CSA flips the paradigm of traditional CSV to "right-size" validation processes. Learn more about the benefits and principles of the CSA approach, which encourages critical thinking and automation.
Previously
ValConnect Innovation Day Princeton: A Glimpse into the Digital Future of Life Sciences
Catalent's Journey of Continuous Improvement for CSV Excellence
Cleaning Validation
Learn how digitization offers a consistent way to carry out cleaning validation lifecycle activities, ensuring your methods and procedures are risk-based and rooted in scientific evidence.
Cleaning Validation in Pharma: FAQs on Limits, Risk, and Control
Explore practical FAQs on cleaning validation in pharma, including regulatory expectations, limits, lifecycle stages, sampling, change control, and digital execution.
Previously
Dirty and Clean Hold Times: Setting Defensible Limits for Cleaning Validation
High-quality Content Straight to Your Inbox!
Join our newsletter to receive updates on the latest news and industry-related content tailored to your preferences.
